SUBSCRIBE
SUBSCRIBE
News   Policy

Sanofi-Aventis (France) Defends Ambien Sleeping Pill

March 23, 2006 | 
1 min read

French pharmaceutical group Sanofi-Aventis defended the safety of Ambien, the top selling sleeping pill in the world, which faces a class action lawsuit that says it causes sleepwalking and eating disorders.

Regulatory Europe
MORE ON THIS TOPIC
Pictured: A scientist works behind an FDA sign/Tay
FDA Tracker
Shorla, Protega Win Expanded Nods for Cancer/Autoimmune, Pain Therapies
October 29, 2024
 · 
195 min read
 · 
Heather McKenzie
FDA signage at its headquarters in Maryland
Approvals
Iterum Wins FDA Approval For Oral UTI Antibiotic, Seeks ‘Strategic Transaction’ for Asset
October 28, 2024
 · 
2 min read
 · 
Tristan Manalac
Exterior view of the headquarters of the Centers for Disease Control and Prevention in Atlanta, Georgia
Vaccines
CDC Reaffirm RSV Vaccination Guidelines, Declines Expanding Coverage to Younger Adults
October 25, 2024
 · 
2 min read
 · 
Tristan Manalac
Novo Nordisk advertising flags and logo on facade
Editorial
Why It’s OK to Talk About Catalent’s Pending Buyout by ‘Novo’
October 24, 2024
 · 
6 min read
 · 
Jef Akst